Partner Content Partner Content Envisagenics presents latest case study at Therapeutics and ... Envisagenics presents latest case study
Partner Content Partner Content Registration opens for Wearable Injectors & Connected Device... Wearable Injectors and Connected Devices
Partner Content Partner Content Exclusive interview with Team Consulting released for Inject... Exclusive interview with Team Consulting released
Partner Content Partner Content Maximising your Virtual Congress Experience maximise virtual congress
Partner Content Partner Content Notified Body BSi Group to lead workshop during Pre-filled S... Notified Body BSi Group to lead workshop
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
